These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37106021)

  • 1. Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory study.
    Yoshida K; Marshe VS; Elsheikh SSM; Maciukiewicz M; Tiwari AK; Brandl EJ; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    Pharmacogenomics J; 2023 Sep; 23(5):119-126. PubMed ID: 37106021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of clinical parameters and polygenic risk scores for body mass index, schizophrenia, and diabetes with antipsychotic-induced weight gain.
    Franz M; Papiol S; Simon MS; Barton BB; Glockner C; Spellmann I; Riedel M; Heilbronner U; Zill P; Schulze TG; Musil R
    J Psychiatr Res; 2024 Jan; 169():184-190. PubMed ID: 38042056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study implicates lipid pathway dysfunction in antipsychotic-induced weight gain: multi-ancestry validation.
    Liao Y; Yu H; Zhang Y; Lu Z; Sun Y; Guo L; Guo J; Kang Z; Feng X; Sun Y; Wang G; Su Z; Lu T; Yang Y; Li W; Lv L; Yan H; Zhang D; Yue W
    Mol Psychiatry; 2024 Jun; 29(6):1857-1868. PubMed ID: 38336841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans.
    Maciukiewicz M; Tiwari AK; Zai CC; Gorbovskaya I; Laughlin CP; Nurmi EL; Liebermann JA; Meltzer HY; Kennedy JL; Müller DJ
    Schizophr Res; 2019 Oct; 212():204-212. PubMed ID: 31447353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the -2548G/A polymorphism of the leptin gene and antipsychotic-induced weight gain: Analysis of the CATIE sample and meta-analysis.
    Yoshida K; Maciukiewicz M; Zai CC; Gonçalves VF; Brandl EJ; Lieberman JA; Meltzer HY; Tiwari AK; Kennedy JL; Müller DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Aug; 102():109952. PubMed ID: 32335267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A hypothesis-driven association study of 28 nuclear-encoded mitochondrial genes with antipsychotic-induced weight gain in schizophrenia.
    Gonçalves VF; Zai CC; Tiwari AK; Brandl EJ; Derkach A; Meltzer HY; Lieberman JA; Müller DJ; Sun L; Kennedy JL
    Neuropsychopharmacology; 2014 May; 39(6):1347-54. PubMed ID: 24196945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications.
    Yu H; Wang L; Lv L; Ma C; Du B; Lu T; Jin C; Yan H; Yang Y; Li W; Ruan Y; Zhang H; Zhang H; Mi W; Mowry B; Ma W; Li K; Zhang D; Yue W
    Schizophr Bull; 2016 May; 42(3):814-23. PubMed ID: 26656879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic validation study of protein tyrosine phosphatase receptor type D (PTPRD) gene variants and risk for antipsychotic-induced weight gain.
    Maciukiewicz M; Gorbovskaya I; Tiwari AK; Zai CC; Freeman N; Meltzer HY; Kennedy JL; Müller DJ
    J Neural Transm (Vienna); 2019 Jan; 126(1):27-33. PubMed ID: 30229349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygenic Hyperlipidemias and Coronary Artery Disease Risk.
    Ripatti P; Rämö JT; Mars NJ; Fu Y; Lin J; Söderlund S; Benner C; Surakka I; Kiiskinen T; Havulinna AS; Palta P; Freimer NB; Widén E; Salomaa V; Tukiainen T; Pirinen M; Palotie A; Taskinen MR; Ripatti S;
    Circ Genom Precis Med; 2020 Apr; 13(2):e002725. PubMed ID: 32154731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The positive association between antipsychotic-induced weight gain and therapeutic response: New biotypes of schizophrenia.
    Lu Z; Zhang Y; Sun Y; Liao Y; Kang Z; Feng X; Yan H; Li J; Wang L; Lu T; Zhang D; Huang Y; Yue W
    Psychiatry Res; 2023 Jun; 324():115226. PubMed ID: 37116323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of SNAP25 variants with schizophrenia and antipsychotic-induced weight change in large-scale schizophrenia patients.
    Guan F; Zhang T; Han W; Zhu L; Ni T; Lin H; Liu D; Chen G; Xiao J; Li T
    Schizophr Res; 2020 Jan; 215():250-255. PubMed ID: 31653583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia.
    Lin BD; Pinzón-Espinosa J; Blouzard E; van der Horst MZ; Okhuijsen-Pfeifer C; van Eijk KR; Guloksuz S; Peyrot WJ; Luykx JJ;
    JAMA Psychiatry; 2023 Feb; 80(2):181-185. PubMed ID: 36542388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the predictive power of polygenic scores derived from genome-wide association studies: a study of 10 complex traits.
    So HC; Sham PC
    Bioinformatics; 2017 Mar; 33(6):886-892. PubMed ID: 28065900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.
    Brandl EJ; Frydrychowicz C; Tiwari AK; Lett TA; Kitzrow W; Büttner S; Ehrlich S; Meltzer HY; Lieberman JA; Kennedy JL; Müller DJ; Puls I
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):134-41. PubMed ID: 22426215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Study of Serotonin 3 Receptor Subunit Gene Variants in Antipsychotic-Induced Weight Gain.
    Zai CC; Tiwari AK; Chowdhury NI; Brandl EJ; Shaikh SA; Freeman N; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    Neuropsychobiology; 2016; 74(3):169-175. PubMed ID: 28531893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene.
    Chowdhury NI; Tiwari AK; Souza RP; Zai CC; Shaikh SA; Chen S; Liu F; Lieberman JA; Meltzer HY; Malhotra AK; Kennedy JL; Müller DJ
    Pharmacogenomics J; 2013 Jun; 13(3):272-9. PubMed ID: 22310352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients With High Genome-Wide Polygenic Risk Scores for Coronary Artery Disease May Receive Greater Clinical Benefit From Alirocumab Treatment in the ODYSSEY OUTCOMES Trial.
    Damask A; Steg PG; Schwartz GG; Szarek M; Hagström E; Badimon L; Chapman MJ; Boileau C; Tsimikas S; Ginsberg HN; Banerjee P; Manvelian G; Pordy R; Hess S; Overton JD; Lotta LA; Yancopoulos GD; Abecasis GR; Baras A; Paulding C;
    Circulation; 2020 Feb; 141(8):624-636. PubMed ID: 31707832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory study on association of genetic variation in TBC1D1 with antipsychotic-induced weight gain.
    Brandl EJ; Tiwari AK; Lett TA; Shaikh SA; Lieberman JA; Meltzer HY; Kennedy JL; Müller DJ
    Hum Psychopharmacol; 2013 Mar; 28(2):183-7. PubMed ID: 23364847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of genome-wide polygenic risk scores for lipid traits and clinical applications for dyslipidemia, subclinical atherosclerosis, and diabetes cardiovascular complications among East Asians.
    Tam CHT; Lim CKP; Luk AOY; Ng ACW; Lee HM; Jiang G; Lau ESH; Fan B; Wan R; Kong APS; Tam WH; Ozaki R; Chow EYK; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JYY; Tsang MW; Kam G; Lau IT; Li JKY; Yeung VTF; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Hu M; Yu W; Tsui SKW; Huang Y; Lan H; Szeto CC; Tang NLS; Ng MCY; So WY; Tomlinson B; Chan JCN; Ma RCW; ;
    Genome Med; 2021 Feb; 13(1):29. PubMed ID: 33608049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.
    Sewell MDE; Jiménez-Sánchez L; Shen X; Edmondson-Stait AJ; Green C; Adams MJ; Rifai OM; McIntosh AM; Lyall DM; Whalley HC; Lawrie SM
    Brain Behav Immun; 2021 Oct; 97():32-41. PubMed ID: 34107350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.